Universitätsklinikum Münster

Hospital


Location: Münster, Germany (DE) DE

ISNI: 0000000405514246

ROR: https://ror.org/01856cw59

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Putative role of 5-HT2Breceptors in migraine pathophysiology (2017) Segelcke D, Meßlinger K Journal article Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma (2017) Zimmer L, Apuri S, Eroglu Z, Kottschade LA, Forschner A, Gutzmer R, Schlaak M, et al. Journal article Differential prognostic value of MYC immunohistochemistry in subtypes of papillary renal cell carcinoma (2017) Bellut J, Bertz S, Nolte E, Stoehr C, Polifka I, Lieb V, Herrmann E, et al. Journal article Intrahepatic cholestasis of pregnancy : Rare but important (2017) Kremer A, Wolf K, Staender S Journal article Pals1 Haploinsufficiency Results in Proteinuria and Cyst Formation (2017) Weide T, Vollenbroeker B, Schulze U, Djuric I, Edeling M, Bonse J, Hochapfel F, et al. Journal article Two-year outcome and risk factors for mortality in patients with coronary artery disease and renal failure: The prospective, observational CAD-REF Registry (2017) Engelbertz C, Reinecke H, Breithardt G, Schmieder R, Fobker M, Fischer D, Schmitz B, et al. Journal article Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma (2017) Einsele H, Knop S, Vogel M, Mueller J, Kropff M, Metzner B, Langer C, et al. Journal article Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology (2017) Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, et al. Journal article Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017) Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, et al. Journal article Allogeneic Hematopoietic Cell Transplantation in Intermediate Risk Acute Myeloid Leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA Mutations (2017) Heidrich K, Thiede C, Schaefer-Eckart K, Schmitz N, Aulitzky WE, Kraemer A, Rösler W, et al. Journal article